STOCK TITAN

West to Host First-Quarter 2025 Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

West Pharmaceutical Services (NYSE: WST) has announced its upcoming first-quarter 2025 financial results release and conference call schedule. The company will disclose its Q1 results before market opening on Thursday, April 24, 2025, followed by a conference call at 9:00 a.m. Eastern Time to discuss financial performance and business expectations.

Interested participants must pre-register for the conference call to receive dial-in details and a unique PIN for asking questions. The event will include a live webcast and slide presentation, accessible through the Investors section of West's website. A replay of both the conference call and webcast will be available on the company website for approximately 90 days following the event.

West Pharmaceutical Services (NYSE: WST) ha annunciato la prossima pubblicazione dei risultati finanziari del primo trimestre 2025 e il programma della conferenza telefonica. L'azienda divulgherà i risultati del Q1 prima dell'apertura del mercato giovedì 24 aprile 2025, seguiti da una conferenza telefonica alle 9:00 ora orientale per discutere delle performance finanziarie e delle aspettative aziendali.

I partecipanti interessati devono registrarsi in anticipo per la conferenza telefonica per ricevere i dettagli per la chiamata e un PIN unico per porre domande. L'evento includerà una trasmissione web in diretta e una presentazione in formato slide, accessibili attraverso la sezione Investitori del sito web di West. Una registrazione sia della conferenza telefonica che della trasmissione web sarà disponibile sul sito dell'azienda per circa 90 giorni dopo l'evento.

West Pharmaceutical Services (NYSE: WST) ha anunciado la próxima publicación de los resultados financieros del primer trimestre de 2025 y el programa de la conferencia telefónica. La compañía revelará sus resultados del Q1 antes de la apertura del mercado el jueves 24 de abril de 2025, seguido de una conferencia telefónica a las 9:00 a.m. hora del Este para discutir el rendimiento financiero y las expectativas comerciales.

Los participantes interesados deben registrarse previamente para la conferencia telefónica y recibir detalles de acceso y un PIN único para hacer preguntas. El evento incluirá una transmisión web en vivo y una presentación de diapositivas, accesibles a través de la sección de Inversores del sitio web de West. Una repetición tanto de la conferencia telefónica como de la transmisión web estará disponible en el sitio web de la empresa durante aproximadamente 90 días después del evento.

웨스트 제약 서비스 (NYSE: WST)는 2025년 1분기 재무 결과 발표 및 컨퍼런스 콜 일정에 대해 발표했습니다. 회사는 2025년 4월 24일 목요일 시장 개장 전에 1분기 결과를 공개하며, 동부 표준시 기준 오전 9:00에 재무 성과 및 사업 기대에 대해 논의하는 컨퍼런스 콜이 이어질 것입니다.

관심 있는 참가자는 컨퍼런스 콜에 미리 등록하여 전화 접속 정보와 질문을 위한 고유 PIN을 받아야 합니다. 이 이벤트는 웨스트 웹사이트의 투자자 섹션을 통해 접근할 수 있는 라이브 웹캐스트 및 슬라이드 프레젠테이션을 포함합니다. 컨퍼런스 콜 및 웹캐스트의 재생은 이벤트 후 약 90일 동안 회사 웹사이트에서 제공될 것입니다.

West Pharmaceutical Services (NYSE: WST) a annoncé la prochaine publication de ses résultats financiers pour le premier trimestre 2025 et le calendrier de la conférence téléphonique. L'entreprise dévoilera ses résultats du Q1 avant l'ouverture du marché le jeudi 24 avril 2025, suivie d'une conférence téléphonique à 9h00, heure de l'Est, pour discuter des performances financières et des attentes commerciales.

Les participants intéressés doivent s'inscrire à l'avance pour la conférence téléphonique afin de recevoir les détails de connexion et un code PIN unique pour poser des questions. L'événement comprendra un webinaire en direct et une présentation de diapositives, accessibles via la section Investisseurs du site web de West. Un enregistrement de la conférence téléphonique et du webinaire sera disponible sur le site de l'entreprise pendant environ 90 jours après l'événement.

West Pharmaceutical Services (NYSE: WST) hat die bevorstehende Veröffentlichung der finanziellen Ergebnisse des ersten Quartals 2025 und den Zeitplan für die Telefonkonferenz angekündigt. Das Unternehmen wird seine Q1-Ergebnisse vor der Markteröffnung am Donnerstag, den 24. April 2025 bekannt geben, gefolgt von einer Telefonkonferenz um 9:00 Uhr Eastern Time, um die finanzielle Leistung und die Geschäftserwartungen zu besprechen.

Interessierte Teilnehmer müssen sich im Voraus für die Telefonkonferenz registrieren, um die Einwahldaten und eine einzigartige PIN für Fragen zu erhalten. Die Veranstaltung umfasst ein Live-Webcast und eine Präsentation, die über den Investorenbereich der Website von West zugänglich sind. Eine Aufzeichnung sowohl der Telefonkonferenz als auch des Webcasts wird etwa 90 Tage nach der Veranstaltung auf der Unternehmenswebsite verfügbar sein.

Positive
  • None.
Negative
  • None.

EXTON, Pa., April 10, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 24, 2025, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

The live webcast can be accessed by clicking here. To ask questions on the conference call, participants need to register in advance by clicking here. Registered telephone participants will receive the dial-in number along with a unique PIN number that will enable them to ask questions on the call. 

A slide presentation will be made available on the day of the call in the Investors section of the Company's website. A replay of the conference call and webcast will be available on the Company's website. Replay of the webcasts will be available for approximately 90 days after the event.

About West

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-host-first-quarter-2025-conference-call-302424869.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

When will West Pharmaceutical Services (WST) release its Q1 2025 earnings?

West Pharmaceutical Services will release its Q1 2025 earnings before the market opens on Thursday, April 24, 2025.

What time is West Pharmaceutical Services' Q1 2025 earnings call?

The Q1 2025 earnings conference call is scheduled for 9:00 a.m. Eastern Time on April 24, 2025.

How can investors participate in West Pharmaceutical Services' Q1 2025 earnings call?

Investors must pre-register to receive dial-in details and a unique PIN. A live webcast will also be available through the company's website.

How long will West Pharmaceutical Services' Q1 2025 earnings call replay be available?

The conference call and webcast replay will be available on the company's website for approximately 90 days after the event.
West Pharm Svcs

NYSE:WST

WST Rankings

WST Latest News

WST Stock Data

15.37B
71.86M
0.59%
97.33%
1.89%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
EXTON